De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells

The recognition of intracellular antigens by CD8<sup>+</sup> T cells through T cell receptors (TCRs) is central for adaptive immunity against infections and cancer. However, the identification of TCRs from patient material remains complex. We present a rapid de novo minibinder (miBd) design platform leveraging state-of-the-art generative models to engineer miBds targeting the cancer-associated peptide-bound major histocompatibility complex (pMHC) SLLMWITQC/HLA-A*02:01 (NY-ESO-1). Incorporating in silico cross-panning enabled computational prescreening of specificity, and molecular dynamics simulations allowed for improved predictability of in vitro success. We identified a high-affinity NY-ESO-1 binder and confirmed its structure using cryo-electron microscopy, which, when incorporated in a chimeric antigen receptor, induced killing of NY-ESO-1<sup>+</sup> melanoma cells. We further designed and validated binders to a neoantigen pMHC complex, RVTDESILSY/HLA-A*01:01, with unknown structure, demonstrating the potential for precision immunotherapy.

Authors

Institutions

Publication Details

Journal
Science
Published
2025-07-24
DOI
https://doi.org/10.1126/science.adv0422
Citations
25
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
26.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells

Johannes R. Loeffler, Suthimon Thumtecho, Sine Reker Hadrup, Monica L. Fernández‐Quintero et al.
25 citations
Science
CAR-T cell therapy research
26.13
article

De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells

Johannes R. Loeffler, Suthimon Thumtecho, Sine Reker Hadrup, Monica L. Fernández‐Quintero, Tripti Tamhane, Lasse Frank Voss, Darian Stephan Wolff, Emma Qingjie Andersen, A Englund, Timothy P. Jenkins, Maria Ormhøj, Kamilla Kjærgaard Munk, Stefano Forli, Kasper Haldrup Björnsson, K. Johansen, Mathilde Due, Esperanza Rivera‐de‐Torre, Max D. Overath, Anant Gharpure, Marie Christine Viuff, Oliver Morell, J Fernandes, Carlos Rodriguez Pardo, Charlotte Risager Christensen, Beatrice Scapolo, Iñigo Lacunza
article en
25 citations

Abstract

The recognition of intracellular antigens by CD8<sup>+</sup> T cells through T cell receptors (TCRs) is central for adaptive immunity against infections and cancer. However, the identification of TCRs from patient material remains complex. We present a rapid de novo minibinder (miBd) design platform leveraging state-of-the-art generative models to engineer miBds targeting the cancer-associated peptide-bound major histocompatibility complex (pMHC) SLLMWITQC/HLA-A*02:01 (NY-ESO-1). Incorporating in silico cross-panning enabled computational prescreening of specificity, and molecular dynamics simulations allowed for improved predictability of in vitro success. We identified a high-affinity NY-ESO-1 binder and confirmed its structure using cryo-electron microscopy, which, when incorporated in a chimeric antigen receptor, induced killing of NY-ESO-1<sup>+</sup> melanoma cells. We further designed and validated binders to a neoantigen pMHC complex, RVTDESILSY/HLA-A*01:01, with unknown structure, demonstrating the potential for precision immunotherapy.

ScienceVol. 389(6758)
Scripps Research Institute (US), Technical University of Denmark (DK)
Good health and well-being
Openalex Percentile: Top 0%
CAR-T cell therapy research
26.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.